| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/21/2011 | WO2010129600A3 Fgf21 mutants and uses thereof |
| 04/21/2011 | WO2010129294A3 Small molecules supporting pluripotent cell growth and methods thereof |
| 04/21/2011 | WO2010104357A4 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 04/21/2011 | WO2010094723A3 Improved anti-serum albumin binding variants |
| 04/21/2011 | WO2010040508A9 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | WO2007011411A3 N-fragment of edema factor as an antigen for immunization against anthrax |
| 04/21/2011 | US20110093984 Gene Capable of Being Expressed Specifically in Endosperm of Plant, Promoter for the Gene, and Use of the Gene and the Promoter |
| 04/21/2011 | US20110093970 Methods and Means to Modify Fiber Strength in Fiber-Producing Plants |
| 04/21/2011 | US20110093966 Plant height regulatory gene and uses thereof |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110093204 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 04/21/2011 | US20110093020 Poly-porous hollow screw for target delivery of growth factors and stem cells:the design and potential clinical application |
| 04/21/2011 | US20110092688 NUCLEIC ACID CONSTRUCT CONTAINING A NUCLEIC ACID DERIVED FROM THE GENOME OF HEPATITIS C VIRUS (HCV) OF GENOTYPE 2a, AND A CELL HAVING SUCH NUCLEIC ACID CONSTRUCT INTRODUCED THEREIN |
| 04/21/2011 | US20110092677 Modified transferin-antibody fusion proteins |
| 04/21/2011 | US20110092675 Fungus-induced inflammation and eosinophil degranulation |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092673 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 04/21/2011 | US20110092672 Nanoparticle and magnetic resonance imaging contrast agent |
| 04/21/2011 | US20110092670 Variants derived from actriib and uses therefor |
| 04/21/2011 | US20110092448 Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics |
| 04/21/2011 | US20110092445 Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses |
| 04/21/2011 | US20110092444 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 04/21/2011 | US20110092441 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 04/21/2011 | US20110092434 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 04/21/2011 | US20110092432 Vascular aging inhibitor and anti-aging formulation |
| 04/21/2011 | US20110092429 Compositions and methods for producing gamma-carboxylated proteins |
| 04/21/2011 | US20110092427 Polypeptide and pharmaceutical composition containing the polypeptide |
| 04/21/2011 | US20110092424 Production of glucagon like peptide 2 and analogs |
| 04/21/2011 | US20110092422 Elastin based growth factor delivery platform for wound healing and regeneration |
| 04/21/2011 | US20110092420 Selenium containing modifying agents and conjugates |
| 04/21/2011 | US20110092419 Protease-stabilized insulin analogues |
| 04/21/2011 | US20110092418 Chimeric Relaxin Polypeptides Comprising an A and B Chain Derived From Different Relaxin Family Peptides |
| 04/21/2011 | US20110092413 Albumin-Fused Kunitz Domain Peptides |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110092388 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/21/2011 | US20110092386 Isolating biological modulators from biodiverse gene fragment libraries |
| 04/21/2011 | US20110092374 Methods for producing substantially homogeneous hybrid or complex n-glycans in methylotrophic yeasts |
| 04/21/2011 | US20110091969 Mutations in the ns5b protein of the hcv |
| 04/21/2011 | US20110091966 Antiviral Peptide Against Hepatitis C Virus |
| 04/21/2011 | US20110091919 pH-INSENSITIVE GLUCOSE INDICATOR PROTEIN |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091868 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 04/21/2011 | US20110091584 Lymphatic vessel stabilizer |
| 04/21/2011 | US20110091502 Human parvovirus: humink parvovirus |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 04/21/2011 | US20110091492 Escherichia coli immunogens with improved solubility |
| 04/21/2011 | US20110091491 Hiv-1 gp41 neutralization domain and use thereof |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091458 Anti-il 13 human antibodies |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091416 Immunoglobulin fusion proteins |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091412 Mutant interleukin-2 (il-2) polypeptides |
| 04/21/2011 | US20110091411 Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases |
| 04/21/2011 | US20110091380 Chlorotoxins as drug carriers |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091377 Biomarkers for melanoma |
| 04/21/2011 | US20110089037 Biological particles |
| 04/21/2011 | CA2813740A1 Recombinant human cc10 protein for treatment of influenza |
| 04/21/2011 | CA2780961A1 Composition for treatment of multiple sclerosis |
| 04/21/2011 | CA2777752A1 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
| 04/21/2011 | CA2777744A1 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites |
| 04/21/2011 | CA2777717A1 Chimeric fibroblast growth factors with altered receptor specificity |
| 04/21/2011 | CA2777700A1 Improved peptidomimetic macrocycles |
| 04/21/2011 | CA2777692A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | CA2777369A1 Quantification of ir-a and ir-b for tumor classification |
| 04/21/2011 | CA2777250A1 Na-k pump modulation |
| 04/21/2011 | CA2777242A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/21/2011 | CA2776392A1 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens |
| 04/21/2011 | CA2776001A1 Mycobacterial vaccines |
| 04/21/2011 | CA2775446A1 Thermophilic mannanohydrolase and fracturing fluids containing the same |
| 04/21/2011 | CA2775277A1 Infectious clones of torque teno virus |
| 04/20/2011 | EP2312318A1 Prion protein ligands and methods of use |
| 04/20/2011 | EP2312312A2 Detection of conformationally altered proteins and prions |
| 04/20/2011 | EP2311991A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311990A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311989A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311988A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311987A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311980A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311979A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/20/2011 | EP2311978A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311972A1 Recombinant N-glycosylated proteins from procaryotic cells |
| 04/20/2011 | EP2311965A1 Glutamine-rich maize seed protein and promoter |
| 04/20/2011 | EP2311964A1 Method to increase stress tolerance in plants |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311958A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/20/2011 | EP2311957A1 Antigens from granulocytic Ehrlichia |
| 04/20/2011 | EP2311956A1 Methods for making APO-2 ligand using divalent metal ions |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |